Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Health Catalyst (HCAT) Other financing activities (2018 - 2024)

Health Catalyst filings provide 3 years of Other financing activities readings, the most recent being -$848000.0 for Q4 2024.

On a quarterly basis, Other financing activities changed N/A to -$848000.0 in Q4 2024 year-over-year; TTM through Dec 2025 was -$848000.0, a 0.0% change, with the full-year FY2024 number at $2.2 million, changed N/A from a year prior.
Other financing activities hit -$848000.0 in Q4 2024 for Health Catalyst, down from $203000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of -$848000.0 in Q4 2024 to a low of -$848000.0 in Q4 2024.